Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POETIC perioperative aromatase inhibitor trial in postmenopausal hormone receptor–positive breast cancer
2007-003877-21Phase 4Unknown
- Sponsor
- The Institute of Cancer Research
- Start
- May 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of anastrozole and letrozole in breast cancer (2 arms), sponsored by The Institute of Cancer Research. Primary endpoint: Relapse-free survival. Status: unknown.
02
Drugs
anastrozoleletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-003877-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003877-21.